Schedule 13G ownership disclosure

GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK

Common Stock · CUSIP: 36266G107

Event date: 2025-09-30

Filing-level shares
24,972,556.00
Percent of class
5.5%
  • Capital Research Global Investors

    Shares: 24,972,556.00 · Class: 5.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001422848-25-000234
Form type
SCHEDULE 13G
Filer
Capital Research Global Investors
CIK
CIK 1422848
Filed
Nov 13, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub